Evidence map›Paper›PMID 35413890›Full record

ArticleBMC public health2022

Correction to: Digital messaging to support control for type 2 diabetes (StAR2D): a multicentre randomised controlled trial.

A Farmer, K Bobrow, N Leon, N Williams, E Phiri, H Namadingo, S Cooper, J Prince, A Crampin, D Besada and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

A Farmer *Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. andrew.farmer@phc.ox.ac.uk.
K Bobrow *Chronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa.
N LeonHealth Systems Research Unit, South-African Medical Research Council, Cape Town, South Africa.
N WilliamsNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
E PhiriMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
H NamadingoMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
S CooperCochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
J PrinceInstitute of Biomedical Engineering, Oxford, UK.
A CrampinMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
D BesadaHealth Systems Research Unit, South-African Medical Research Council, Cape Town, South Africa.
E DaviaudHealth Systems Research Unit, South-African Medical Research Council, Cape Town, South Africa.
L-M YuNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
J N'gomaKamuzu Central Hospital, Lilongwe, Malawi.
D SpringerBoston Consulting Group, London, UK.
B PaulyDepartment of Diabetes and Endocrinology, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
L TarassenkoInstitute of Biomedical Engineering, Oxford, UK.
S NorrisHuman Nutrition Unit, South African Medical Research Council, Johannesberg, South Africa.
M NyirendaMalawi Epidemiology and Intervention Research Unit, Lilongwe, Malawi.
N LevittChronic Disease Initiative for Africa, University of Cape Town, Cape Town, South Africa.

Funding

Medical Research Council MR/M016498/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35413890
PMCPMC9006479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.